Pell Bio-Med Technology Co., Ltd. (6949)
Market Closed
10 Aug, 05:30
TWSE TWSE Primary NT$
948. 00
+5
+0.5302%
NT$
36.78B Market Cap
- P/E Ratio
- Div Yield
243,204 Volume
- Eps
NT$ 943
Previous Close Want to track 6949 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Pell Bio-Med Technology Co., Ltd. (6949) Statistics
Valuation metrics
Market Cap 36.78B
Enterprise value 59.79B
Trailing P/E (ttm) -133
Forward P/E -
PEG ratio 14.72
Price/Sales (ttm) 2,391.07
Price/Book (mrq) 23
Enterprise Value/Revenue 2,313.33
Enterprise Value/EBITDA -140.51
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 198.42K
Average volume (90 days) 220.78K
Price summary
52-Week low 308.5
52-Week high 1,120
Beta -
50-Day moving average 919.8
200-Day moving average 726.16
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -17.02%
Operating margin -18.23%
Operational effectiveness
Return on assets -0.13%
Return on equity -0.29%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.4
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -6.78
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 37.74
Total debt (mrq) -
Total Debt/Equity (mrq) 0.09
Current ratio (mrq) 9.6%
Book value per share (mrq) 45.02
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
